FDA Inspection 1115984 — Women & Infants Hospital Of Rhode Island Women & Infants' Fertility Center

Women & Infants Hospital Of Rhode Island Women & Infants' Fertility Center — FEI 3006146324

The FDA completed an inspection of Women & Infants Hospital Of Rhode Island Women & Infants' Fertility Center on January 27, 2020 in Providence, RI. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
January 27, 2020
Fiscal Year
2020
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Providence, RI (United States)

Citations

IDCFRDescription
1221321 CFR 1271.47(a)Testing, screening, donor eligibility procedures
1227721 CFR 1271.75(a)(1)Risk factors, clinical evidence